2月28日，总部设在新加坡的生物科技公司KBP Biosciences Pte. Ltd. （下称KBP）发表声明，回应新加坡国际商事法院（SICC）近期作出的裁决。SICC于2025年2月 ...

近期，全球制药巨头诺和诺德（Novo Nordisk）向新加坡生物技术公司KBP Biosciences（中文名：亨利医药，以下简称“KBP”）及其创始人黄振华提起高达8.3 ...

The KBP lawyer also shared that while there are other broadcasters on free TV, which he estimated at more than 30 players, they are not producing content like how ABS-CBN did it. “ABS-CBN ...

Feb 18 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is seeking up to $830 million in damages from KBP Biosciences, according to a ruling by a Singapore court, as the Danish drugmaker says it ...